A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention

Jason H Wasfy1, Kenneth Rosenfield, Katya Zelevinsky

  • 1Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Insights

Hospitals can now identify patients at high risk for 30-day readmission after percutaneous coronary intervention (PCI). Developed prediction models use pre-PCI and discharge data to target interventions and reduce readmissions.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Predictive Analytics

Background:

  • The Affordable Care Act incentivizes hospitals to reduce readmissions for conditions like percutaneous coronary intervention (PCI).
  • Identifying high-risk patients for 30-day readmission post-PCI is crucial for effective intervention.

Purpose of the Study:

  • To develop and validate prediction models for identifying patients at high risk of 30-day readmission after PCI.
  • To aid clinicians and hospitals in targeted readmission prevention strategies.

Main Methods:

  • Utilized a two-thirds random sample of 36,060 PCI patients in Massachusetts (2005-2008) for model development.
  • Developed two models: one using pre-PCI variables and another using discharge variables.
  • Validated models on the remaining one-third of patients, assessing discrimination and calibration.

Main Results:

  • 10.4% of PCI patients (3760) were readmitted within 30 days.
  • Key pre-PCI predictors included age, female sex, insurance type, congestive heart failure, and chronic kidney disease.
  • Discharge predictors included lack of beta-blocker prescription, complications, and extended length of stay. The Discharge model showed modest improvement in prediction (C-statistic=0.69).

Conclusions:

  • Validated prediction models can effectively identify patients at high risk for readmission after PCI.
  • These models enable targeted interventions to prevent costly and potentially avoidable readmissions.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...